Eli Lilly and Company's CEO Salary

Eli Lilly and Company's CEO salary and other executives compensation in 2025 was as follows:

David A. Ricks Chair, President, and Chief Executive Officer at Eli Lilly and Company, received a total compensation of $36.70 M in 2025.
Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs at Eli Lilly and Company, received a total compensation of $17.79 M in 2025.
Anat Hakim Executive Vice President, General Counsel and Secretary at Eli Lilly and Company, received a total compensation of $9.85 M in 2025.
Lucas Montarce Executive Vice President and Chief Financial Officer at Eli Lilly and Company, received a total compensation of $8.48 M in 2025.
Jake Van Naarden Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development at Eli Lilly and Company, received a total compensation of $7.59 M in 2025.

CEO/ Executive salary tells one part of the story. Explore Employee Count Trend, Revenue per Employee, and Profit per Employee to understand workforce scale, and employee productivity.

David A. Ricks Chair, President, and Chief Executive Officer

Per Year
Per Month
Per Week
Per Day

David A. Ricks Chair, President, and Chief Executive Officer, at Eli Lilly and Company, received $1.70 M in base salary, $23.33 M in stock award, and $5.19 M in other compensation, making $36.70 M in total compensation in 2025.

The total compensation was +25.49% up from the previous year, 2024.

Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs

Per Year
Per Month
Per Week
Per Day

Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs, at Eli Lilly and Company, received $1.49 M in base salary, $12.00 M in stock award, and $1.05 M in other compensation, making $17.79 M in total compensation in 2025.

The total compensation was +40.73% up from the previous year, 2024.

Anat Hakim Executive Vice President, General Counsel and Secretary

Per Year
Per Month
Per Week
Per Day

Anat Hakim Executive Vice President, General Counsel and Secretary, at Eli Lilly and Company, received $1.00 M in base salary, $6.00 M in stock award, and $665.52 K in other compensation, making $9.85 M in total compensation in 2025.

The total compensation was +31.65% up from the previous year, 2024.

Lucas Montarce Executive Vice President and Chief Financial Officer

Per Year
Per Month
Per Week
Per Day

Lucas Montarce Executive Vice President and Chief Financial Officer, at Eli Lilly and Company, received $1.00 M in base salary, $5.00 M in stock award, and $303.32 K in other compensation, making $8.48 M in total compensation in 2025.

The total compensation was +187.71% up from the previous year, 2024.

Jake Van Naarden Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development

Per Year
Per Month
Per Week
Per Day

Jake Van Naarden Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development, at Eli Lilly and Company, received $920.19 K in base salary, $4.50 M in stock award, and $159.89 K in other compensation, making $7.59 M in total compensation in 2025.

The total compensation was +31.38% up from the previous year, 2024.

Executive	2025	2024	2023
David A. Ricks Chair, President, and Chief Executive Officer	$36.70 M	••••••••	••••••••
Base Salary	$1.70 M	••••••••	••••••••
Incentive Plan Compensation	$6.49 M	••••••••	••••••••
All Other Compensation	$5.19 M	••••••••	••••••••
Stock Award	$23.33 M	••••••••	••••••••
Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs	$17.79 M	••••••••	••••••••
Base Salary	$1.49 M	••••••••	••••••••
Incentive Plan Compensation	$3.25 M	••••••••	••••••••
All Other Compensation	$1.05 M	••••••••	••••••••
Stock Award	$12.00 M	••••••••	••••••••
Anat Hakim Executive Vice President, General Counsel and Secretary	$9.85 M	••••••••	••••••••
Base Salary	$1.00 M	••••••••	••••••••
Incentive Plan Compensation	$2.18 M	••••••••	••••••••
All Other Compensation	$665.52 K	••••••••	••••••••
Stock Award	$6.00 M	••••••••	••••••••
Lucas Montarce Executive Vice President and Chief Financial Officer	$8.48 M	••••••••	••••••••
Base Salary	$1.00 M	••••••••	••••••••
Incentive Plan Compensation	$2.18 M	••••••••	••••••••
All Other Compensation	$303.32 K	••••••••	••••••••
Stock Award	$5.00 M	••••••••	••••••••
Jake Van Naarden Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development	$7.59 M	••••••••	••••••••
Base Salary	$920.19 K	••••••••	••••••••
Incentive Plan Compensation	$2.01 M	••••••••	••••••••
All Other Compensation	$159.89 K	••••••••	••••••••
Stock Award	$4.50 M	••••••••	••••••••
Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology	-	••••••••	••••••••
Base Salary	-	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	-	••••••••	••••••••
Stock Award	-	••••••••	••••••••
Jake Van Naarden Executive Vice President and President, Loxo@Lilly	-	••••••••	••••••••
Base Salary	-	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	-	••••••••	••••••••
Stock Award	-	••••••••	••••••••
Anat Ashkenazi Executive Vice President and Chief Financial Officer	-	••••••••	••••••••
Base Salary	-	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	-	••••••••	••••••••
Stock Award	-	••••••••	••••••••
Gordon Brooks Interim CFO and Group Vice President - Controller and Corporate Strategy	-	••••••••	••••••••
Base Salary	-	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	-	••••••••	••••••••
Stock Award	-	••••••••	••••••••

To access the data, Sign up for free

Submit feedback to Bullfincher

Eli Lilly and Company's CEO Salary

David A. Ricks Chair, President, and Chief Executive Officer

Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs

Anat Hakim Executive Vice President, General Counsel and Secretary

Lucas Montarce Executive Vice President and Chief Financial Officer

Jake Van Naarden Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development

Executive Compensation Summary Table

Related

People Also Search For

Submit feedback to Bullfincher